Kyorin University / 杏林大学
University / College
Location:
Tokyo,
Japan (JP)
ISNI: 0000000093402869
ROR: https://ror.org/0188yz413
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials (2024)
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, et al.
Journal article
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy (2024)
Colombel JF, Hisamatsu T, Atreya R, Bresso F, Thin L, Panaccione R, Parra RS, et al.
Journal article
Normalisation of biomarkers and improvement in clinical outcomes in patients with Crohn's Disease treated with risankizumab in the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies (2022)
Atreya R, Feagan B, Shchukina O, Jairath V, Rieder F, Hisamatsu T, Siegmund B, et al.
Conference contribution
Mechanism-based treatment strategies for IBD: Cytokines, cell adhesion molecules, JAK inhibitors, gut flora, and more (2019)
Schreiner P, Neurath M, Ng SC, El-Omar EM, Sharara AI, Kobayashi T, Hisamatsu T, et al.
Journal article, Review article
Helicobacter pylori in Human Diseases Advances in Microbiology, Infectious Diseases and Public Health Volume 11 Preface (2019)
Kamiya S, Backert S
Journal article, Editorial